Search
BioCryst Pharmaceuticals Inc
BCRXAdd to Watchlist
8.920USD
-0.140-1.55%
Close 06/16, 16:00（ET）Quotes delayed by 15 min
2.27BMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States (Country)
548.78M
91.18%
Other
38.66M
6.42%
Outside of U.S.
14.40M
2.39%
By Business
By Region
Relevant data have not been disclosed by the company yet.
